AVTX logo

AVTXAvalo Therapeutics Inc

$13.10
$0.51
(3.75%)
Today
Closed $13.10
$0.26
(1.99%)
After Hours
Updated: 07:35 PM EDT
Reported EarningsMay 13
Mkt Cap$688.61M
Vol1.76M

About

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
33

Frequently Asked Questions

What is Market Cap of Avalo Therapeutics Inc?
What is the 52-week high for Avalo Therapeutics Inc?
What is the 52-week low for Avalo Therapeutics Inc?
What is Avalo Therapeutics Inc stock price today?
What was Avalo Therapeutics Inc stock price yesterday?
What is the PE ratio of Avalo Therapeutics Inc?
What is the Price-to-Book ratio of Avalo Therapeutics Inc?
What is the 50-day moving average of Avalo Therapeutics Inc?
How many employees does Avalo Therapeutics Inc have?

Advertisement|Remove ads.